Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,03 CAD | -.--% | +20,00% | -.--% |
Vakgebied
Verkoop per activiteit
CAD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Psychoactive Compounds, Development of Natural Health Care Products, and Mental Health Treatments
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Verkoop per regio
CAD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Tim Moore
CEO | Chief Executive Officer | 66 | 06-05-20 |
Jenna Pozar
COO | Chief Operating Officer | - | 01-03-21 |
Director/Board Member | - | 04-09-20 | |
Ivan Casselman
BRD | Director/Board Member | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Tim Moore
CEO | Chief Executive Officer | 66 | 06-05-20 |
Ivan Casselman
BRD | Director/Board Member | - | - |
Director/Board Member | - | 04-09-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 28 646 020 | 27 642 020 ( 96,50 %) | 0 | 96,50 % |
Bedrijfsgegevens
HAVN Life Sciences, Inc.
130 Brew Street Suite 605
V3H 0E3, Port Moody
+604 370 9520
http://www.havnlife.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-.--% | 625K | |
+26,28% | 42,68 mld. | |
-3,99% | 42,4 mld. | |
+45,32% | 40,04 mld. | |
-6,20% | 28,31 mld. | |
+6,36% | 24,94 mld. | |
-21,47% | 18,96 mld. | |
+27,58% | 12,3 mld. | |
-2,75% | 11,95 mld. | |
-2,02% | 11,55 mld. |
- Beurs
- Aandelen
- Koers HAVN
- Onderneming HAVN Life Sciences Inc.